Joel Lazewatsky
Joel Lazewatsky
Director, Clinical Imaging, Lantheus Medical Imaging
Verified email at
Cited by
Cited by
Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 …
DS Berman, J Maddahi, BK Tamarappoo, J Czernin, R Taillefer, ...
Journal of the American College of Cardiology 61 (4), 469-477, 2013
Design, Synthesis, and Evaluation of Radiolabeled Integrin αvβ3 Receptor Antagonists for Tumor Imaging and Radiotherapy
TD Harris, S Kalogeropoulos, T Nguyen, S Liu, J Bartis, C Ellars, ...
Cancer Biotherapy and radiopharmaceuticals 18 (4), 627-641, 2003
Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a …
J Maddahi, J Czernin, J Lazewatsky, SC Huang, M Dahlbom, H Schelbert, ...
Journal of Nuclear Medicine 52 (9), 1490-1498, 2011
Evaluation of LMI1195, a Novel 18F-Labeled Cardiac Neuronal PET Imaging Agent, in Cells and Animal Models
M Yu, J Bozek, M Lamoy, M Guaraldi, P Silva, M Kagan, P Yalamanchili, ...
Circulation: Cardiovascular Imaging 4 (4), 435-443, 2011
Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid.
C Orlandi, PD Crane, DS Edwards, SH Platts, L Bernard, J Lazewatsky, ...
Journal of nuclear medicine: official publication, Society of Nuclear …, 1991
MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent
C von Bary, M Makowski, A Preissel, A Keithahn, A Warley, E Spuentrup, ...
Circulation: Cardiovascular Imaging 4 (2), 147-155, 2011
Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation
AJ Sinusas, J Lazewatsky, J Brunetti, G Heller, A Srivastava, YH Liu, ...
Journal of Nuclear Medicine 55 (9), 1445-1451, 2014
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic …
JA Barrett, AC Crocker, DJ Damphousse, SJ Heminway, S Liu, ...
Bioconjugate chemistry 8 (2), 155-160, 1997
Dual-gated motion-frozen cardiac PET with flurpiridaz F 18
PJ Slomka, M Rubeaux, L Le Meunier, D Dey, JL Lazewatsky, T Pan, ...
Journal of Nuclear Medicine 56 (12), 1876-1881, 2015
Method and apparatus for the secure printing of a document
M Sharma
US Patent 6,977,745, 2005
Automatic 3D registration of dynamic stress and rest 82Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction
J Woo, B Tamarappoo, D Dey, R Nakazato, L Le Meunier, A Ramesh, ...
Medical physics 38 (11), 6313-6326, 2011
Structure−Activity Relationships of 111In- and 99mTc-Labeled Quinolin-4-one Peptidomimetics as Ligands for the Vitronectin Receptor:  Potential Tumor Imaging …
TD Harris, S Kalogeropoulos, T Nguyen, G Dwyer, DS Edwards, S Liu, ...
Bioconjugate chemistry 17 (5), 1294-1313, 2006
Technetium-99m (Sn2+) pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons
JA Bianco, AJ Kemper, A Taylor, J Lazewatsky, DE Tow, SF Khuri
Journal of Nuclear Medicine 24 (6), 485-491, 1983
Bottom fixation type integrated circuit chip cooling structure
Y Lai
US Patent 6,874,568, 2005
Tc-99m-labeled fibrinogen receptor antagonists: design and synthesis of cyclic RGD peptides for the detection of thrombi
TD Harris, M Rajopadhye, PR Damphousse, D Glowacka, K Yu, ...
Bioorganic & Medicinal Chemistry Letters 6 (15), 1741-1746, 1996
Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents
TD Harris, E Cheesman, AR Harris, R Sachleben, DS Edwards, S Liu, ...
Bioconjugate chemistry 18 (4), 1266-1279, 2007
Methods and apparatus for synthesizing imaging agents, and intermediates thereof
RR Cesati, EH Cheesman, J Lazewatsky, HS Radeke, E Mongeau, ...
US Patent 8,936,777, 2015
BMS753951: a novel low molecular weight magnetic resonance contrast agent selective for arterial wall imaging
D Onthank, P Yalamanchili, R Cesati, J Lazewatsky, M Azure, M Hayes, ...
Circulation 116 (suppl_16), II_411-II_412, 2007
Contrast agents for applications including perfusion imaging
SP Robinson, DS Casebier, M Yu, M Kagan, J Lazewatsky
US Patent 9,408,927, 2016
Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice
PD Crane, DC Onthank, CR Bourque, SJ Heminway, TJ Mazaika, I Leav, ...
Journal of Nuclear Medicine 36 (10), 1862-1868, 1995
The system can't perform the operation now. Try again later.
Articles 1–20